China National Medicines Corporation Ltd. (SHA:600511)

Market Cap	22.05B -3.1%
Revenue (ttm)	51.95B +1.5%
Net Income	2.01B -7.1%
EPS	2.67 -7.1%
Shares Out	754.50M
PE Ratio	10.97
Forward PE	10.43
Dividend	0.80 (2.74%)
Ex-Dividend Date	Jun 18, 2025

Volume	7,778,315
Average Volume	6,022,304
Open	29.17
Previous Close	29.13
Day's Range	29.06 - 29.43
52-Week Range	27.57 - 32.39
Beta	0.33
RSI	53.61
Earnings Date	Mar 20, 2026

About SHA:600511

China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental academic services, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. op...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 3,104
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2024, SHA:600511's revenue was 50.60 billion, an increase of 1.81% compared to the previous year's 49.70 billion. Earnings were 2.00 billion, a decrease of -6.80%.